COVID RT-PCR rest kit @ Rs 150 from Biogenex

Detects Omicron without RNA extraction

BioGenex Life Sciences has developed an RT-PCR kit for Covid-19 diagnosis, including Omicron.

HYDERABAD, Jan 7 (The CONNECT) - BioGenex Life Sciences Pvt Ltd, a Hyderabad-based and USA- headquartered company, developed an RT-PCR kit for Covid-19 diagnosis, including Omicron and other variants. The kit detects Omicron without RNA extraction in half the time than standard PCR, Dr. Krishan Kalra, CEO of the company said today.  The kit, called The TRIPLEX COVID-19 RT-PCR Direct that is priced at Rs 150 plus taxes, is launched nationally at Hyderabad now.

The National Institute of Biologicals (NIB), Noida, an ICMR-designated lab, examined the performance of this kit and found that it performed with 100% accuracy &100% sensitivity which means no false negatives or positives, which will significantly control the pandemic through accurate diagnosis. The kit detects the Omicron variant in half the time than the standard RT-PCR tests, Dr Kalra said.

NIB is an APEX autonomous Institute under the administrative control of the Union Ministry of Health & Family Welfare, Government of India engaged in Quality Control Evaluation of various biological products like vaccines, blood products, blood reagents, sera, Immuno-diagnostic kits etc. produced and imported into India. 

The TRIPLEX COVID-19 RT-PCR Direct is a real-time RT-PCR test intended for the qualitative detection of SARS-CoV-2 directly from the upper respiratory swab, nasopharyngeal or oropharyngeal swabs, collected in preservative media, (VTM/UTM), pH 7.2-7.4 to provide the molecular diagnostic basis for infected patients.

Recent News